Gene analysis of congenital connective tissue disorders using human collagen gene probes

使用人类胶原蛋白基因探针对先天性结缔组织疾病进行基因分析

基本信息

  • 批准号:
    62570445
  • 负责人:
  • 金额:
    $ 1.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1987
  • 资助国家:
    日本
  • 起止时间:
    1987 至 1989
  • 项目状态:
    已结题

项目摘要

1. Analysis of Clooagen Protein Molecules Newly synthesized [3H]proline-labeled proteins produced by skin fibroblasts from eighteen cases of Marfan syndrome, nine cases of Ehlers-Danlos syndrome and seven cases of osteogenesis imperfecta were investigated. We found fibroblasts derived from a patient with osteogenesis imperfecta type II ( lethal form ) produced shortened pro alpha1(I)chain. Further precise analysis revealed that there was a mutaion in CB8 peptide of alpha1(I)chain (a middle portion of triple-herical lesion). In other all cases, we could not detect any abnormalities of type I and III procollagen. However, unusual 185 KDa collagenous protein was synthesized by skin fibroblasts from four patients with marfan syndrome. We identified the 185 KDa band as type IV collagen by immunoprecipitaion and CNBr peptide mapping.2. Gene Analysis Using Collagen Gene Probes DNA purified from fibroblasts were digested with various kinds of restriction enzymes and were electrophoresed on agarose gels followed by transfered to nitrocelluroce membranes. We analysed the DNA with gene probes of human type I procollagen; Hf677, NJ3 and Nj1/4.1 by southern blotting. So far we could not detect any abnormalities in any cases.3. Linkage Study of Marfan Syndrome Families with Type I Procollagen Gene We did linkage analysis using restriction fragment length polymorphism ( RFLP ) in the pro alpha2(I)chain by Southern blotting. Before doing the linkage analysis, we checked allelic frequencies of both probes. Allelic frequencies of MspI RFLP and EcoRI RFLP positive were 83% and 69%, respectively. Analysis showed no linkage in two Marfan families, and the probes were not useful in one family.
1. Clooagen蛋白分子的分析研究了18例马凡综合征、9例Ehlers-Danlos综合征和7例成骨肉瘤患者皮肤成纤维细胞产生的新合成[3 H]脯氨酸标记蛋白。我们发现成纤维细胞来源于成骨细胞II型(致死型)患者产生缩短的pro α 1(I)链。进一步的精确分析表明,CB 8 α 1(I)链肽段(三重螺旋损伤的中间部分)发生了突变。在其他所有情况下,我们不能检测到任何异常的I型和III型前胶原。然而,不寻常的185 kDa的胶原蛋白合成的皮肤成纤维细胞从4例马凡综合征。通过免疫沉淀和CNBr肽图分析,确定185 KDa条带为IV型胶原.使用胶原基因探针的基因分析将从成纤维细胞纯化的DNA用各种限制性内切酶消化,并在琼脂糖凝胶上电泳,然后转移到硝酸纤维素膜上。我们用人Ⅰ型前胶原基因探针Hf 677、NJ 3和Nj 1/4.1进行DNA的Southern印迹分析。到目前为止,我们在任何情况下都没有发现任何异常。马凡氏综合征家系与Ⅰ型前胶原基因的连锁研究我们用限制性片段长度多态性(RFLP)技术对pro α 2(Ⅰ)链进行了连锁分析。在进行连锁分析之前,我们检查了两个探针的等位基因频率。MspI和EcoR Ⅰ RFLP的等位基因频率分别为83%和69%。分析表明,在两个马凡家族中没有连锁,探针在一个家庭中无效。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yasunori.Okada,et al.: FEBS Lett. (1989)
Yasunori.Okada 等人:FEBS Lett。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hajime Sawada: Experimental Cell Research. 171. 94-109 (1987)
Hajime Sawada:实验细胞研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KONOMI Hiroshi其他文献

KONOMI Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Mechanistic investigation into Frizzled-2 signaling for treatment of Osteogenesis Imperfecta
Frizzled-2 信号传导治疗成骨不全症的机制研究
  • 批准号:
    10680236
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta
早期抗肌生长抑制素治疗成骨不全症的临床前测试
  • 批准号:
    10840238
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Lung developmental defects caused by type I collagen mutations in mouse models of osteogenesis imperfecta
成骨不全小鼠模型中 I 型胶原蛋白突变引起的肺发育缺陷
  • 批准号:
    10735577
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Targeting TGFb In Osteogenesis Imperfecta
靶向 TGFb 治疗成骨不全症
  • 批准号:
    10736736
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Investigating pulmonary complications due to abnormal collagen/ER stress in Osteogenesis Imperfecta
研究成骨不全症中胶原蛋白/内质网应激异常引起的肺部并发症
  • 批准号:
    10556308
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Conditional mouse models with dominant negative Osteogenesis Imperfecta
显性负性成骨不全的条件小鼠模型
  • 批准号:
    10646852
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta
成骨不全中骨骼祖细胞的调节
  • 批准号:
    10528208
  • 财政年份:
    2022
  • 资助金额:
    $ 1.54万
  • 项目类别:
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta
成骨不全中骨骼祖细胞的调节
  • 批准号:
    10665057
  • 财政年份:
    2022
  • 资助金额:
    $ 1.54万
  • 项目类别:
Novel bone specific pharmacological treatment for osteogenesis imperfecta
治疗成骨不全症的新型骨特异性药物治疗
  • 批准号:
    10455615
  • 财政年份:
    2021
  • 资助金额:
    $ 1.54万
  • 项目类别:
Novel bone specific pharmacological treatment for osteogenesis imperfecta
治疗成骨不全症的新型骨特异性药物治疗
  • 批准号:
    10317353
  • 财政年份:
    2021
  • 资助金额:
    $ 1.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了